Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Pharmascience Group Directors Deals (OXP)

  • There is currently no data for OXP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Deals for Oxford Pharmascience Group (OXP)

Announced Traded Action Notifier Price Currency Amount Holding
30-Jun-1526-Jun-15Notification of HoldingMarcelo Bravo held the position of Chief Technology Officer at the time of this trade.Marcelo Bravo---65,000,000
24-Jun-1524-Jun-15Notification of HoldingMarcelo Bravo held the position of Chief Technology Officer at the time of this trade.Marcelo Bravo---65,000,000
24-Jun-1524-Jun-15Notification of HoldingDavid Robert Norwood held the position of Non-Executive Chairman at the time of this trade.David Robert Norwood---105,938,633
26-Mar-1425-Mar-14BuyDavid Robert Norwood held the position of Non-Executive Chairman at the time of this trade.David Robert Norwood4.30GBX1,000,000105,938,633
17-Oct-1316-Oct-13Notification of HoldingDavid Robert Norwood held the position of Non-Executive Chairman at the time of this trade.David Robert Norwood---104,938,633
20-Mar-1327-Feb-13Notification of HoldingMichael Anthony Bretherton held the position of Finance Director at the time of this trade.Michael Anthony Bretherton---37,871,472
02-Nov-1102-Nov-11PlacingMarcelo Bravo held the position of Chief Technology Officer at the time of this trade.Marcelo Bravo1.00GBX2,500,00065,000,000
02-Nov-1102-Nov-11PlacingDavid Robert Norwood held the position of Non-Executive Chairman at the time of this trade.David Robert Norwood1.00GBX10,000,00097,514,300

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.